Terry Rosen, Ph.D.

Terry Rosen, Ph.D.

Chief Executive Officer and DirectoratArcus Biosciences· In proxies 2021–2025

Pay in FY2025+33% from the year before

Terry Rosen, Ph.D. was paid $9.7M in FY2025 (Dec), up 33%.

PayNo stock prices for these years
Pay is from the Summary Compensation Table of each Arcus Biosciences proxy. The stock line is the value of $100 put in the stock at the start, from the price change of each fiscal year. Dividends are not in it.

Experience

  1. Arcus BiosciencesPublic company · 5 yr
    • Chief Executive Officer and Director2021 – Present · 5 yrNo stock prices for these years
  2. Epiodyne, Inc.Public company
    • Director? – PresentNo stock prices for these years
  3. IDEAYA Biosciences, Inc.Public company
    • Director? – PresentNo stock prices for these years
  4. Simcha Therapeutics Holding Company, LLCPublic company
    • Director? – PresentNo stock prices for these years
  5. Sonoma Biotherapeutics, Inc.Public company
    • Director? – PresentNo stock prices for these years
  6. PACT Pharma, Inc.Public company · 6 yr
    • Director2016 – 2022 · 6 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?